
PTC Therapeutics Stock Jumps After $2 Billion Novartis Deal
PTC Therapeutics Stock Jumps After $2 Billion Novartis DealKey Highlights:PTC Therapeutics' stock surged 16% after announcing a major licensing deal with Novartis.The deal grants Novartis global right...